Synageva BioPharma Corp (NASDAQ:GEVA)

214.25
Delayed Data
As of 2:40pm ET
 -1.52 / -0.70%
Today’s Change
60.19
Today|||52-Week Range
218.80
+130.90%
Year-to-Date

Today’s Trading

Previous close215.77
Today’s open215.19
Day’s range213.45 - 215.80
Volume183,086
Average volume (3 months)786,209
Market cap$8.0B
Dividend yield--
Data as of 2:40pm ET, 05/28/2015

Growth & Valuation

Earnings growth (last year)-73.24%
Earnings growth (this year)-25.49%
Earnings growth (next 5 years)+36.00%
Revenue growth (last year)-51.46%
P/E ratioNM
Price/Sales467.65
Price/Book15.21

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc+1.51+0.80%
XONIntrexon Corp-0.42-1.02%
JUNOJuno Therapeutics In...+1.45+3.11%
CTLTCatalent Inc+0.55+1.77%
Data as of 2:55pm ET, 05/28/2015

Financials

Next reporting dateJuly 29, 2015
EPS forecast (this quarter)-$1.79
Annual revenue (last year)$6.5M
Annual profit (last year)-$192.6M
Net profit margin-2,967.47%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Sanj K. Patel
Chief Operating Officer
Robert B. Bazemore
Corporate headquarters
Lexington, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers